Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 89 Pages
Report ld: 4513922
Request Sample
Customized Report
Erythromycin Thiocyanate API Market Size(US$)

CAGR 2025-2031
5.5%
Market Size,2031
USD 2,387
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
North American market for Erythromycin Thiocyanate API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Erythromycin Thiocyanate API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Erythromycin Thiocyanate API include Yili Chuannig Biotechnology, Yichang East Sunshine, Alebi Pharma, META Pharmaceuticals, Anuh Pharma, HEC Group, AbbVie, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Erythromycin Thiocyanate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythromycin Thiocyanate API.
The Erythromycin Thiocyanate API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erythromycin Thiocyanate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erythromycin Thiocyanate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erythromycin Thiocyanate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Erythromycin Thiocyanate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Erythromycin Thiocyanate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Erythromycin Thiocyanate API Market Overview
1.1 Product Definition
1.2 Erythromycin Thiocyanate API by Type
1.2.1 Global Erythromycin Thiocyanate API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Industrial Grade
1.2.3 Feed Grade
1.2.4 Pharmaceutical Grade
1.3 Erythromycin Thiocyanate API by Application
1.3.1 Global Erythromycin Thiocyanate API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Erythromycin Synthesis
1.3.3 Feed Additive
1.4 Global Market Growth Prospects
1.4.1 Global Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Erythromycin Thiocyanate API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Erythromycin Thiocyanate API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Erythromycin Thiocyanate API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Erythromycin Thiocyanate API Production Market Share by Manufacturers (2020-2025)
2.2 Global Erythromycin Thiocyanate API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Erythromycin Thiocyanate API, Industry Ranking, 2023 VS 2024
2.4 Global Erythromycin Thiocyanate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Erythromycin Thiocyanate API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Erythromycin Thiocyanate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Erythromycin Thiocyanate API, Product Offered and Application
2.8 Global Key Manufacturers of Erythromycin Thiocyanate API, Date of Enter into This Industry
2.9 Erythromycin Thiocyanate API Market Competitive Situation and Trends
2.9.1 Erythromycin Thiocyanate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Erythromycin Thiocyanate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Erythromycin Thiocyanate API Production by Region
3.1 Global Erythromycin Thiocyanate API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Erythromycin Thiocyanate API Production Value by Region (2020-2031)
3.2.1 Global Erythromycin Thiocyanate API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Erythromycin Thiocyanate API by Region (2026-2031)
3.3 Global Erythromycin Thiocyanate API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Erythromycin Thiocyanate API Production Volume by Region (2020-2031)
3.4.1 Global Erythromycin Thiocyanate API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Erythromycin Thiocyanate API by Region (2026-2031)
3.5 Global Erythromycin Thiocyanate API Market Price Analysis by Region (2020-2025)
3.6 Global Erythromycin Thiocyanate API Production and Value, Year-over-Year Growth
3.6.1 North America Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2020-2031)
4 Erythromycin Thiocyanate API Consumption by Region
4.1 Global Erythromycin Thiocyanate API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Erythromycin Thiocyanate API Consumption by Region (2020-2031)
4.2.1 Global Erythromycin Thiocyanate API Consumption by Region (2020-2025)
4.2.2 Global Erythromycin Thiocyanate API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Erythromycin Thiocyanate API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Erythromycin Thiocyanate API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Erythromycin Thiocyanate API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Erythromycin Thiocyanate API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Erythromycin Thiocyanate API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Erythromycin Thiocyanate API Production by Type (2020-2031)
5.1.1 Global Erythromycin Thiocyanate API Production by Type (2020-2025)
5.1.2 Global Erythromycin Thiocyanate API Production by Type (2026-2031)
5.1.3 Global Erythromycin Thiocyanate API Production Market Share by Type (2020-2031)
5.2 Global Erythromycin Thiocyanate API Production Value by Type (2020-2031)
5.2.1 Global Erythromycin Thiocyanate API Production Value by Type (2020-2025)
5.2.2 Global Erythromycin Thiocyanate API Production Value by Type (2026-2031)
5.2.3 Global Erythromycin Thiocyanate API Production Value Market Share by Type (2020-2031)
5.3 Global Erythromycin Thiocyanate API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Erythromycin Thiocyanate API Production by Application (2020-2031)
6.1.1 Global Erythromycin Thiocyanate API Production by Application (2020-2025)
6.1.2 Global Erythromycin Thiocyanate API Production by Application (2026-2031)
6.1.3 Global Erythromycin Thiocyanate API Production Market Share by Application (2020-2031)
6.2 Global Erythromycin Thiocyanate API Production Value by Application (2020-2031)
6.2.1 Global Erythromycin Thiocyanate API Production Value by Application (2020-2025)
6.2.2 Global Erythromycin Thiocyanate API Production Value by Application (2026-2031)
6.2.3 Global Erythromycin Thiocyanate API Production Value Market Share by Application (2020-2031)
6.3 Global Erythromycin Thiocyanate API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Yili Chuannig Biotechnology
7.1.1 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Company Information
7.1.2 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Product Portfolio
7.1.3 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Yili Chuannig Biotechnology Main Business and Markets Served
7.1.5 Yili Chuannig Biotechnology Recent Developments/Updates
7.2 Yichang East Sunshine
7.2.1 Yichang East Sunshine Erythromycin Thiocyanate API Company Information
7.2.2 Yichang East Sunshine Erythromycin Thiocyanate API Product Portfolio
7.2.3 Yichang East Sunshine Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Yichang East Sunshine Main Business and Markets Served
7.2.5 Yichang East Sunshine Recent Developments/Updates
7.3 Alebi Pharma
7.3.1 Alebi Pharma Erythromycin Thiocyanate API Company Information
7.3.2 Alebi Pharma Erythromycin Thiocyanate API Product Portfolio
7.3.3 Alebi Pharma Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Alebi Pharma Main Business and Markets Served
7.3.5 Alebi Pharma Recent Developments/Updates
7.4 META Pharmaceuticals
7.4.1 META Pharmaceuticals Erythromycin Thiocyanate API Company Information
7.4.2 META Pharmaceuticals Erythromycin Thiocyanate API Product Portfolio
7.4.3 META Pharmaceuticals Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 META Pharmaceuticals Main Business and Markets Served
7.4.5 META Pharmaceuticals Recent Developments/Updates
7.5 Anuh Pharma
7.5.1 Anuh Pharma Erythromycin Thiocyanate API Company Information
7.5.2 Anuh Pharma Erythromycin Thiocyanate API Product Portfolio
7.5.3 Anuh Pharma Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Anuh Pharma Main Business and Markets Served
7.5.5 Anuh Pharma Recent Developments/Updates
7.6 HEC Group
7.6.1 HEC Group Erythromycin Thiocyanate API Company Information
7.6.2 HEC Group Erythromycin Thiocyanate API Product Portfolio
7.6.3 HEC Group Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 HEC Group Main Business and Markets Served
7.6.5 HEC Group Recent Developments/Updates
7.7 AbbVie
7.7.1 AbbVie Erythromycin Thiocyanate API Company Information
7.7.2 AbbVie Erythromycin Thiocyanate API Product Portfolio
7.7.3 AbbVie Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 AbbVie Main Business and Markets Served
7.7.5 AbbVie Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Erythromycin Thiocyanate API Industry Chain Analysis
8.2 Erythromycin Thiocyanate API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Erythromycin Thiocyanate API Production Mode & Process Analysis
8.4 Erythromycin Thiocyanate API Sales and Marketing
8.4.1 Erythromycin Thiocyanate API Sales Channels
8.4.2 Erythromycin Thiocyanate API Distributors
8.5 Erythromycin Thiocyanate API Customer Analysis
9 Erythromycin Thiocyanate API Market Dynamics
9.1 Erythromycin Thiocyanate API Industry Trends
9.2 Erythromycin Thiocyanate API Market Drivers
9.3 Erythromycin Thiocyanate API Market Challenges
9.4 Erythromycin Thiocyanate API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 143
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 95
USD 3950.00
(Single User License)
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 129
USD 2900.00
(Single User License)
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 78
USD 4250.00
(Single User License)
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 95
USD 3950.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 91
USD 2900.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 108
USD 4350.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 137
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 143
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 95
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 129
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 145
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 78
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 95
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 91
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 108
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 137
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now